<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Our Approach - Alix</title>
    <link rel="stylesheet" href="our-approach.css?v=4">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <!-- Instrument Serif -->
    <link href="https://fonts.googleapis.com/css2?family=Instrument+Serif:ital,wght@0,400;1,400&display=swap" rel="stylesheet">
    <!-- IBM Plex Sans -->
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans:ital,wght@0,400;0,500;0,600;0,700;1,400&display=swap" rel="stylesheet">
</head>
<body>
    <!-- Header/Navigation Bar -->
    <header class="header-bar">
        <!-- Logo -->
        <a href="index.html" class="logo">Alix</a>
        
        <!-- Line separator -->
        <div class="line-container" aria-hidden="true"></div>
        
        <!-- Navigation -->
        <nav class="navigation">
            <a href="our-approach.html" class="nav-item nav-approach active">Our Approach</a>
            <a href="portfolio.html" class="nav-item nav-portfolio">Portfolio</a>
            <a href="team.html" class="nav-item nav-team">Team</a>
            <a href="https://bios.fm" target="_blank" class="nav-item nav-bios">Bios ↗</a>
        </nav>
    </header>
    
    <main class="content-wrapper">
        <!-- Alix Definition -->
        <div class="definition-section">
            <h1 class="definition-title">Alix</h1>
            <p class="pronunciation">/ˈælɪks /</p>
            <p class="part-of-speech">Noun</p>
            <p class="definition-text">Derived from names of Germanic origin; meaning "defending warrior," "helper of mankind" and "noble"</p>
        </div>
        
        <!-- Separator Line -->
        <div class="separator-line"></div>
        
        <!-- Our Thesis -->
        <section class="content-section">
            <h2 class="section-header">Our Thesis</h2>
            <p class="section-text">At Alix Ventures, we partner with early-stage startups harnessing TechBio to drive breakthroughs in human health. We believe tech-first biology is the frontier of radical innovation in the life sciences.</p>
        </section>
        
        <!-- From Molecules to Modalities -->
        <section class="content-section">
            <h3 class="section-subheader">From Molecules to Modalities</h3>
            <p class="section-text">The birth of biotech began with Genentech in the 1970s. Unlocking industrial-scale production of biologic medicines marked the start of using engineering to catalyze momentous advancements in healthcare. Over the last four decades, we've seen continued waves of innovation powered by molecular engineering: PCR, DNA fingerprinting, antibody-based treatments at Regeneron, rational drug design at Vertex, CRISPR-Cas9, FDA-approved CAR-T cell therapy, synthetic biology, and many others. In a remarkably short period of time, we've arrived at a point where we can design and manufacture virtually any biological material imaginable.</p>
            <p class="section-text">Engineering will remain at the core of next-generation biology. Computational and data-driven approaches will unlock new therapeutics, materials, platforms, and entirely new modalities. Catalyzed by code and machines, progressive futures that once seemed distant will soon envelope our day-to-day lives.</p>
        </section>
        
        <!-- Why We Exist -->
        <section class="content-section">
            <h3 class="section-subheader">Why We Exist</h3>
            <p class="section-text"><em>Biology is becoming a programmable technology stack. Venture hasn't kept up.</em></p>
            <p class="section-text">Today, we're facing another threshold moment. Modern labs look less like artisanal workshops and more like data centers. Assays scale like software systems. Biological systems can be explored, perturbed, and optimized with unprecedented precision.</p>
            <p class="section-text">As technology converges with life sciences, founders are building fundamentally new categories of companies. Neither "biotech" nor "tech," but engineering-native biology platforms capable of compounding software to impact human health at scale.</p>
            <p class="section-text">At Alix, we back the technologies driving this shift. We strive to understand the core problems in an industry and find founders with bold solutions. We invest early, back the best people, and move with conviction.</p>
        </section>
        
        <!-- How We Invest -->
        <section class="content-section">
            <h3 class="section-subheader">How We Invest</h3>
            <p class="section-text">Where biology becomes programmable.</p>
            <p class="section-text">Whether discovery engines, engineered cells, new modalities, or healthcare infrastructure, we invest where biology becomes a scalable, repeatable, and leverage-generating system.</p>
            
            <div class="invest-subsection">
                <h4 class="invest-header">I. Manufacturing</h4>
                <p class="section-text">The scientific method is slow. Human-driven wet lab workflows can't keep pace with the demands of modern drug discovery. Biology can't reshape human health if it can't scale.</p>
                <p class="section-text">Every assay and piece of equipment in the lab is following Moore's law-like curves in cost, scale, fidelity, and reproducibility. We're investing in automated, high-throughput, data-rich platforms that compress timelines, reduce costs, and generate dense datasets.</p>
            </div>
            
            <div class="invest-subsection">
                <h4 class="invest-header">II. Therapeutics</h4>
                <p class="section-text">The design space of biology is expanding exponentially. From full-stack DNA writing to non-viral delivery and programmable cell systems, we're unlocking precise control over expression, trafficking, targeting, and cellular behavior.</p>
                <p class="section-text">We invest in therapeutic platforms that behave like engines rather than one-off assets. This includes cell therapies designed with industrial logic, targeted delivery systems built from first principles, and molecular platforms that generate pipelines across multiple diseases.</p>
                <p class="section-text">This programmable toolkit forms the substrate on which the next era of indication-agnostic genetic and cell-based medicines will be built.</p>
            </div>
            
            <div class="invest-subsection">
                <h4 class="invest-header">III. Infrastructure</h4>
                <p class="section-text">Brilliant science is fruitless if it can't navigate the complex path from bench to bedside. Innovation only translates if a ripe ecosystem is in place to support it.</p>
                <p class="section-text">We're looking for founders addressing the bottlenecks that slow clinical development and care delivery: workforce gaps, fragmented data, and mismanaged patient populations. We invest in tools that are purpose-built for organizations translating scientific inventions into outcomes, automating our industry, while making it more data-transparent and scalable.</p>
            </div>
        </section>
        
        <!-- The Future We're Building -->
        <section class="content-section">
            <h3 class="section-subheader">The Future We're Building</h3>
            <p class="section-text">At Alix, we're creating the future we were promised, today.</p>
            <p class="section-text">Partnering with and stewarding this next generation of companies fueled by biological transformation will mobilize massive impact for humanity, our goal is to power a world that makes health, longevity, and biological design accessible at a global scale. To do this, we're running headlong against the status quo and rewriting prior art in investing, company operations, team construction, and go-to-market models.</p>
            <p class="section-text"><em>The techno-scientific proof is already here. The constituent building blocks exist today. Our collective task is to write and execute the playbooks.</em></p>
            <p class="join-text">Join us.</p>
        </section>
    </main>
    
    <!-- Footer -->
    <footer class="site-footer">
        <div class="footer-content">
            <div class="footer-social">
                <a href="https://www.linkedin.com/company/alix-ventures" target="_blank" class="social-icon linkedin" aria-label="LinkedIn">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433c-1.144 0-2.063-.926-2.063-2.065 0-1.138.92-2.063 2.063-2.063 1.14 0 2.064.925 2.064 2.063 0 1.139-.925 2.065-2.064 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z"/>
                    </svg>
                </a>
                <a href="https://www.youtube.com/channel/UCWadRaYPrE1kE4t9LuCd28w" target="_blank" class="social-icon youtube" aria-label="YouTube">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M23.498 6.186a3.016 3.016 0 0 0-2.122-2.136C19.505 3.545 12 3.545 12 3.545s-7.505 0-9.377.505A3.017 3.017 0 0 0 .502 6.186C0 8.07 0 12 0 12s0 3.93.502 5.814a3.016 3.016 0 0 0 2.122 2.136c1.871.505 9.376.505 9.376.505s7.505 0 9.377-.505a3.015 3.015 0 0 0 2.122-2.136C24 15.93 24 12 24 12s0-3.93-.502-5.814zM9.545 15.568V8.432L15.818 12l-6.273 3.568z"/>
                    </svg>
                </a>
                <a href="https://twitter.com/bios_community" target="_blank" class="social-icon twitter" aria-label="Twitter">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-5.214-6.817L4.99 21.75H1.68l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z"/>
                    </svg>
                </a>
            </div>
            <div class="footer-columns">
                <div class="footer-column">
                    <h3 class="footer-heading">COMPANY</h3>
                    <ul class="footer-links">
                        <li><a href="team.html">Team</a></li>
                        <li><a href="portfolio.html">Companies</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">INSIGHTS</h3>
                    <ul class="footer-links">
                        <li><a href="https://bios.fm" target="_blank">BIOS</a></li>
                        <li><a href="our-approach.html">Our Approach</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">RESOURCES</h3>
                    <ul class="footer-links">
                        <li><a href="partners.html">Venture Partners</a></li>
                        <li><a href="portfolio.html">Portfolio</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">CONTACT</h3>
                    <ul class="footer-links">
                        <li><a href="mailto:partners@alix.vc">Contact Us</a></li>
                    </ul>
                </div>
            </div>
        </div>
        <div class="footer-bottom">
            <p class="footer-copyright">© Alix Ventures 2025</p>
        </div>
    </footer>
    
    <script src="our-approach.js"></script>
</body>
</html>
